News

Public · Published

Schrodinger Inc reports results for the quarter ended September 30 - Earnings Summary

Schrodinger reported an adjusted quarterly loss of 50 cents per share for the quarter ended September 30, compared with a larger loss a year earlier and analysts' expected 70-cent loss. Revenue rose 18.7% to $64.49 million, above the $47.26 million analysts expected, while the company reported a $37.71 million quarterly loss.

Published:

Updated:

What happened

Schrodinger reported an adjusted quarterly loss of 50 cents per share for the quarter ended September 30, compared with a larger loss a year earlier and analysts’ expected 70-cent loss. Revenue rose 18.7% to $64.49 million, above the $47.26 million analysts expected, while the company reported a $37.71 million quarterly loss.

Confirmed

Global impact / market context

Revenue growth above analysts’ expectations suggests stronger sales than anticipated, while the narrower adjusted loss indicates improved performance on that measure. However, the reported quarterly loss shows the business remained unprofitable, so sustained revenue growth and control of costs matter to its path toward profitability.

Analyst inference

Analysts’ average rating was “buy,” but their median 12-month price target of $24.00 was about 18.8% below the last closing price of $28.52. Shares had declined 12.5% this quarter while gaining 52.0% year to date, a mixed backdrop for investors weighing results against expectations.

Confirmed

What to watch

  1. Watch whether revenue growth continues in subsequent results; sustained sales growth would help establish whether the 18.7% year-over-year increase can support progress toward profitability. Analyst inference
  2. Track the reported loss and adjusted loss per share separately, because adjusted results exclude certain items and may not reflect the full cost of running the business. Analyst inference
  3. Analysts made no earnings estimate revisions in the last 30 days, while their average estimate had risen about 3.6% over three months; future revisions could indicate changing expectations. Confirmed

Evidence

  • Original source link unavailable